通过抑制IKK/IκB/NF-κB轴,KDF1促进了乳腺细胞分化
Hangbo Liu1, Miao Yu1, Kai Sun1
1Department of Prosthodontics, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing, China.
Journal of cellular physiology
|September 20, 2024
概括
角质细胞分化因子1 (KDF1) 通过调节乳腺细胞分化,促进牙面膜的形成. KDF1抑制NF-κB通路,这表明它有可能用于质再生疗法.
科学领域:
- 牙科研究 牙科研究
- 细胞生物学 细胞生物学
- 发展的分子机制的发展.
背景情况:
- 牙面膜的形成对牙健康至关重要.
- 杏仁细胞分化是牙发展的关键.
- 皮细胞分化因子1 (KDF1) 在乳腺生成中的作用尚不清楚.
研究的目的:
- 为了研究KDF1在乳腺细胞分化中的功能.
- 阐明KDF1在质形成中的调节机制.
- 探索KDF1作为质再生的目标.
主要方法:
- RNAscope在位杂交和免疫光测试检测KDF1的表达.
- 在LS8细胞中进行KDF1操纵的CRISPR/Cas-9基因编辑和lentiviral载体.
- 定量逆转录PCR,西斑,ALP测定,液体染色学-质谱学和共免疫沉以分析分子变化和相互作用.
主要成果:
- 在整个 ameloblast 分化过程中,KDF1 得到表达.
- 在LS8细胞中KDF1的操纵改变了关键的氨基基生殖标记物和性酸酶活性的表达.
- KDF1与IKK复合体相互作用,抑制NF-κB通路.
- 抑制NF-κB部分挽救了KDF1-Knockout诱导的细胞分化缺陷.
结论:
- 通过抑制IKK/IκB/NF-κB信号通路,KDF1促进了乳腺细胞分化.
- KDF1是质形成的一个重要因素.
- KDF1代表了增强功能性质再生的潜在治疗标.
相关概念视频
NF-κB-dependent Signaling Pathway
7.3K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.3K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


